Literature DB >> 33353156

Cell Death in Liver Diseases: A Review.

Layla Shojaie1,2, Andrea Iorga1,2, Lily Dara1,2.   

Abstract

Regulated cell death (RCD) is pivotal in directing the severity and outcome of liver injury. Hepatocyte cell death is a critical event in the progression of liver disease due to resultant inflammation leading to fibrosis. Apoptosis, necrosis, necroptosis, autophagy, and recently, pyroptosis and ferroptosis, have all been investigated in the pathogenesis of various liver diseases. These cell death subroutines display distinct features, while sharing many similar characteristics with considerable overlap and crosstalk. Multiple types of cell death modes can likely coexist, and the death of different liver cell populations may contribute to liver injury in each type of disease. This review addresses the known signaling cascades in each cell death pathway and its implications in liver disease. In this review, we describe the common findings in each disease model, as well as the controversies and the limitations of current data with a particular focus on cell death-related research in humans and in rodent models of alcoholic liver disease, non-alcoholic fatty liver disease and steatohepatitis (NASH/NAFLD), acetaminophen (APAP)-induced hepatotoxicity, autoimmune hepatitis, cholestatic liver disease, and viral hepatitis.

Entities:  

Keywords:  NASH; RIPK1; RIPK3; apoptosis; ferroptosis; hepatocytes; hepatotoxicity; necroptosis; necrosis; pyroptosis

Mesh:

Year:  2020        PMID: 33353156      PMCID: PMC7766597          DOI: 10.3390/ijms21249682

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  278 in total

Review 1.  Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion.

Authors:  Alan Cahill; Carol C Cunningham; Masayuki Adachi; Hiromasa Ishii; Shannon M Bailey; Bernard Fromenty; Adrian Davies
Journal:  Alcohol Clin Exp Res       Date:  2002-06       Impact factor: 3.455

2.  In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.

Authors:  Tarik Asselah; Ivan Bièche; Abdellah Mansouri; Ingrid Laurendeau; Dominique Cazals-Hatem; Gérard Feldmann; Pierre Bedossa; Valérie Paradis; Michelle Martinot-Peignoux; Didier Lebrec; Cécile Guichard; Eric Ogier-Denis; Michel Vidaud; Zéra Tellier; Vassili Soumelis; Patrick Marcellin; Richard Moreau
Journal:  J Pathol       Date:  2010-07       Impact factor: 7.996

3.  Immunoblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice.

Authors:  N R Pumford; J A Hinson; R W Benson; D W Roberts
Journal:  Toxicol Appl Pharmacol       Date:  1990-07       Impact factor: 4.219

4.  Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.

Authors:  H Miyoshi; C Rust; P J Roberts; L J Burgart; G J Gores
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

Review 5.  The inflammasome in liver injury and non-alcoholic fatty liver disease.

Authors:  Wajahat Zafar Mehal
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

6.  Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.

Authors:  Paul J Pockros; Eugene R Schiff; Mitchell L Shiffman; John G McHutchison; Robert G Gish; Nezam H Afdhal; Manana Makhviladze; Mira Huyghe; David Hecht; Tilman Oltersdorf; David A Shapiro
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

7.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

8.  Hepatitis C Virus Infection of Cultured Human Hepatoma Cells Causes Apoptosis and Pyroptosis in Both Infected and Bystander Cells.

Authors:  H M Kofahi; N G A Taylor; K Hirasawa; M D Grant; R S Russell
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

9.  NLRP3 receptor contributes to protection against experimental antigen-mediated cholangitis.

Authors:  Marisol Ibet González; Danielle Vannan; Bertus Eksteen; José Luis Reyes
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

10.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Authors:  N Takahashi; L Duprez; S Grootjans; A Cauwels; W Nerinckx; J B DuHadaway; V Goossens; R Roelandt; F Van Hauwermeiren; C Libert; W Declercq; N Callewaert; G C Prendergast; A Degterev; J Yuan; P Vandenabeele
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

View more
  29 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

2.  ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment.

Authors:  Wali Muhammad; Jiaqi Zhu; Zihe Zhai; Jieqi Xie; Jiahang Zhou; Xudong Feng; Bing Feng; Qiaoling Pan; Shifen Li; Rajiu Venkatesan; Pan Li; Hongcui Cao; Changyou Gao
Journal:  Acta Biomater       Date:  2022-06-18       Impact factor: 10.633

3.  Factors Involved in the Apoptotic Cell Death Mechanism in Yellow Fever Hepatitis.

Authors:  Jeferson da Costa Lopes; Luiz Fábio Magno Falcão; Arnaldo Jorge Martins Filho; Marcos Luiz Gaia Carvalho; Caio Cesar Henriques Mendes; Fábio Alves Olímpio; Vanessa do Socorro Cabral Miranda; Lais Carneiro Dos Santos; Jannifer Oliveira Chiang; Ana Cecilia Ribeiro Cruz; Vanessa Costa Alves Galúcio; Raimunda do Socorro da Silva Azevedo; Lívia Caricio Martins; Maria Irma Seixas Duarte; Jorge Rodrigues de Sousa; Pedro Fernando da Costa Vasconcelos; Juarez Antônio Simões Quaresma
Journal:  Viruses       Date:  2022-06-01       Impact factor: 5.818

4.  Pyroptosis impacts the prognosis and treatment response in gastric cancer via immune system modulation.

Authors:  Wanli Yang; Liaoran Niu; Xinhui Zhao; Lili Duan; Xiaoqian Wang; Yiding Li; Junfeng Chen; Wei Zhou; Yujie Zhang; Daiming Fan; Liu Hong
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

5.  ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation.

Authors:  Di Lu; Qiaoyun Xia; Zhiyu Yang; Shanjun Gao; Suofeng Sun; Xiaoying Luo; Zhen Li; Xiulei Zhang; Shuangyin Han; Xiuling Li; Mingbo Cao
Journal:  Ann Transl Med       Date:  2021-04

Review 6.  The Emerging Role of Ferroptosis in Liver Diseases.

Authors:  Si Chen; Jun-Yao Zhu; Xin Zang; Yong-Zhen Zhai
Journal:  Front Cell Dev Biol       Date:  2021-12-14

Review 7.  Insight into microRNAs-Mediated Communication between Liver and Brain: A Possible Approach for Understanding Acute Liver Failure?

Authors:  Karolina Orzeł-Gajowik; Krzysztof Milewski; Magdalena Zielińska
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

8.  Simultaneous Inhibition of Three Major Cytokines and Its Therapeutic Effects: A Peptide-Based Novel Therapy against Endotoxemia in Mice.

Authors:  Hung-Jen Shih; Chao-Yuan Chang; Milton Chiang; Van Long Le; Hao-Jen Hsu; Chun-Jen Huang
Journal:  J Pers Med       Date:  2021-05-20

9.  Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway.

Authors:  Tingyi Du; Qin Fang; Zhihao Zhang; Chuanmeng Zhu; Renfan Xu; Guangzhi Chen; Yan Wang
Journal:  Metabolites       Date:  2022-01-10

Review 10.  Is the Macrophage Phenotype Determinant for Fibrosis Development?

Authors:  Lluis Lis-López; Cristina Bauset; Marta Seco-Cervera; Jesús Cosín-Roger
Journal:  Biomedicines       Date:  2021-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.